WEBVTT 00:00:00.000 --> 00:00:02.740 Welcome to The Deep Dive, the show where we really 00:00:02.740 --> 00:00:05.500 get into the details behind the headlines, focusing 00:00:05.500 --> 00:00:07.980 on the most crucial insights from authoritative 00:00:07.980 --> 00:00:10.720 sources. Glad to be here. Today, we're tackling 00:00:10.720 --> 00:00:13.500 something that honestly affects so many people. 00:00:14.279 --> 00:00:18.399 That... really persistent, nagging shoulder pain, 00:00:18.480 --> 00:00:20.359 you know, the kind, I mean, where everyday things 00:00:20.359 --> 00:00:23.719 suddenly feel impossible. Oh, absolutely. Reaching 00:00:23.719 --> 00:00:25.699 up for something on a high shelf or even just 00:00:25.699 --> 00:00:27.600 trying to get comfortable at night, it can be 00:00:27.600 --> 00:00:30.019 incredibly disruptive. Exactly. We're talking 00:00:30.019 --> 00:00:32.979 about rotator cuff tears and specifically the 00:00:32.979 --> 00:00:35.200 really difficult ones, the ones surgeons often 00:00:35.200 --> 00:00:38.460 call massive rotator cuff tears. These aren't 00:00:38.460 --> 00:00:41.659 just minor strains. They can be genuinely debilitating 00:00:41.659 --> 00:00:44.380 injuries, really impacting daily life, work, 00:00:44.520 --> 00:00:47.100 sleep, everything. And repairing them has been, 00:00:47.119 --> 00:00:49.299 well, a major challenge in orthopedics for a 00:00:49.299 --> 00:00:52.200 long time, hasn't it? For decades, yes. Standard 00:00:52.200 --> 00:00:54.479 surgical techniques, while they often work well 00:00:54.479 --> 00:00:57.520 for smaller tears, they frequently struggle when 00:00:57.520 --> 00:00:59.979 it comes to these really large, complex injuries. 00:01:00.200 --> 00:01:02.200 Leaving patients sometimes with ongoing pain, 00:01:02.380 --> 00:01:04.620 maybe limited movement, and even the possibility 00:01:04.620 --> 00:01:07.239 of needing more surgery down the line? That's 00:01:07.239 --> 00:01:09.819 the unfortunate reality for some, yes. Which 00:01:09.819 --> 00:01:11.659 leads us to why we're doing this deep dive today. 00:01:11.859 --> 00:01:14.959 Right. Our mission today is to explore a solution 00:01:14.959 --> 00:01:18.359 that's been evolving rapidly and is frankly pretty 00:01:18.359 --> 00:01:21.439 groundbreaking. Patch augmentation. Think of 00:01:21.439 --> 00:01:24.239 it as adding a reinforcement to that torn tendon. 00:01:25.000 --> 00:01:27.400 But it's more than just a physical patch. It's 00:01:27.400 --> 00:01:29.719 often designed to be biologically active too. 00:01:29.900 --> 00:01:32.019 So we want to unpack what these patches actually 00:01:32.019 --> 00:01:34.670 are, how they're supposed to work. you know, 00:01:34.790 --> 00:01:36.510 biomechanically and maybe even at a cellular 00:01:36.510 --> 00:01:39.430 level to help the body heal itself. And crucially, 00:01:39.670 --> 00:01:42.390 what the real -world impact has been. What does 00:01:42.390 --> 00:01:44.390 the evidence tell us about how well they work 00:01:44.390 --> 00:01:46.909 for patients? We'll look at the science, the 00:01:46.909 --> 00:01:49.209 successes, and yeah, probably some of the setbacks, 00:01:49.409 --> 00:01:51.170 too, because that's how medical innovation works, 00:01:51.269 --> 00:01:53.390 right? It's rarely a straight path. Definitely 00:01:53.390 --> 00:01:55.870 not. And our main guide for this discussion is 00:01:55.870 --> 00:01:58.890 a really thorough comprehensive systematic review. 00:01:59.170 --> 00:02:02.469 It's titled Rotator Cuff Repair with Patch Augmentation. 00:02:02.810 --> 00:02:05.450 What do we know? Okay. It was published back 00:02:05.450 --> 00:02:08.590 in October 2022 in the archives of bone and joint 00:02:08.590 --> 00:02:11.050 surgery. And it's important to stress this isn't 00:02:11.050 --> 00:02:13.639 just one study. Right. It's a review. It pulls 00:02:13.639 --> 00:02:16.020 together lots of research. Exactly. It synthesizes 00:02:16.020 --> 00:02:18.840 a huge amount of existing literature. It represents 00:02:18.840 --> 00:02:21.080 the collective knowledge and experience of a 00:02:21.080 --> 00:02:24.139 team of leading orthopedic specialists from various 00:02:24.139 --> 00:02:26.539 places. And what's really valuable here for our 00:02:26.539 --> 00:02:29.039 deep dive is that this specific review was co 00:02:29.039 --> 00:02:31.259 -authored by a team of highly respected experts 00:02:31.259 --> 00:02:33.639 in the field. Yes. Including Professor Mohammed 00:02:33.639 --> 00:02:36.469 Elitmi Mom. His background in orthopedic surgery 00:02:36.469 --> 00:02:39.270 and research, his work at places like Ashford 00:02:39.270 --> 00:02:42.449 and St. Peter's NHS Foundation Trust, the Fortius 00:02:42.449 --> 00:02:46.030 Clinic in London. It's extensive. His contributions 00:02:46.030 --> 00:02:48.490 and those of his co -authors are really central 00:02:48.490 --> 00:02:51.650 to understanding these complex challenges and 00:02:51.650 --> 00:02:54.150 the innovations trying to address them. So their 00:02:54.150 --> 00:02:56.250 expertise really provides the foundation for 00:02:56.250 --> 00:02:58.250 everything we're going to discuss today. It sets 00:02:58.250 --> 00:03:00.669 the stage for a really in -depth exploration. 00:03:00.870 --> 00:03:02.949 Precisely. OK, so let's start by really defining 00:03:02.949 --> 00:03:04.909 the scale of the problem, because understanding 00:03:04.909 --> 00:03:06.650 the challenge helps us appreciate why things 00:03:06.650 --> 00:03:09.729 like patch augmentation even came about. Absolutely. 00:03:09.930 --> 00:03:12.830 The review makes it clear. Massive rotator cuff 00:03:12.830 --> 00:03:16.770 tears remain a really significant hurdle in orthopedic 00:03:16.770 --> 00:03:18.830 surgery. Even with all the tech advancements, 00:03:19.189 --> 00:03:21.490 better instruments, refined techniques. Even 00:03:21.490 --> 00:03:25.689 with all that. Despite decades of progress, the 00:03:25.689 --> 00:03:28.310 healing rates for these bigger, more complex 00:03:28.310 --> 00:03:32.169 tears are still, well, quite variable. Some patients 00:03:32.169 --> 00:03:37.030 do great, others not so much. Exactly. And predicting 00:03:37.030 --> 00:03:39.930 who will do well has been surprisingly difficult. 00:03:40.150 --> 00:03:42.349 It's not always straightforward. So the goal 00:03:42.349 --> 00:03:44.250 of the surgery itself is pretty clear, right? 00:03:44.310 --> 00:03:46.330 You want to fix the tear. The primary objectives 00:03:46.330 --> 00:03:48.729 are twofold. First, improve the patient's symptoms. 00:03:49.400 --> 00:03:52.240 reduce pain, restore function, and second, improve 00:03:52.240 --> 00:03:54.180 the structural integrity of the rotator cuff 00:03:54.180 --> 00:03:57.000 itself. You want that tendon to heal back to 00:03:57.000 --> 00:04:00.280 the bone properly. But here's where it gets complicated. 00:04:00.599 --> 00:04:02.620 As the review points out, sometimes patients 00:04:02.620 --> 00:04:05.139 feel better, their function improves. Even if 00:04:05.139 --> 00:04:07.699 the repair fails structurally, meaning the tendon 00:04:07.699 --> 00:04:10.360 actually re -tears later on. That seems counterintuitive. 00:04:10.500 --> 00:04:12.650 How can you feel better if it's torn again? The 00:04:12.650 --> 00:04:15.289 body is amazing at compensating. Other muscles 00:04:15.289 --> 00:04:17.410 can take over. Inflammation might settle down 00:04:17.410 --> 00:04:20.250 initially, but that underlying structural failure 00:04:20.250 --> 00:04:23.269 is a major concern. And the rates of these re 00:04:23.269 --> 00:04:26.129 -tears, especially for large and massive tears, 00:04:26.389 --> 00:04:29.029 are quite high. Shockingly high in some studies. 00:04:29.610 --> 00:04:31.610 The paper cites research reporting recurrent 00:04:31.610 --> 00:04:36.350 tearing in as many as 94 % of these cases. 94%, 00:04:36.350 --> 00:04:39.089 wow. It's a sobering statistic. It means that 00:04:39.089 --> 00:04:40.990 even if things look good right after surgery, 00:04:41.389 --> 00:04:43.670 Follow -up imaging, maybe an MRI a year or two 00:04:43.670 --> 00:04:46.110 later, might show the tendon has torn again. 00:04:46.470 --> 00:04:48.490 That really drives home the point you made. Feeling 00:04:48.490 --> 00:04:50.910 better isn't always the same as being structurally 00:04:50.910 --> 00:04:53.610 healed. It's a critical distinction. And it highlights 00:04:53.610 --> 00:04:56.629 the need for solutions that promote genuine biological 00:04:56.629 --> 00:04:59.629 healing, not just temporary symptom relief. The 00:04:59.629 --> 00:05:02.209 review mentions more data, too. A big meta -analysis 00:05:02.209 --> 00:05:05.170 from 2015. Yes, involving over 8 ,000 patients. 00:05:05.730 --> 00:05:08.689 It found that overall, around 26 .6 % of all 00:05:08.689 --> 00:05:11.449 rotator cuff repairs fail to heal structurally. 00:05:11.730 --> 00:05:14.069 So roughly a quarter. That's a huge number across 00:05:14.069 --> 00:05:15.990 the board. It really underscores the scale of 00:05:15.990 --> 00:05:17.610 the problem we're talking about. It's not a news 00:05:17.610 --> 00:05:20.860 issue. So the big question, then, is why? Why 00:05:20.860 --> 00:05:23.779 do so many repairs fail to heal, especially these 00:05:23.779 --> 00:05:26.779 larger ones? The paper points to a few key factors. 00:05:27.860 --> 00:05:30.160 First and foremost is offer the tissue quality 00:05:30.160 --> 00:05:32.800 itself. Meaning the tendon is already damaged. 00:05:33.060 --> 00:05:36.300 Exactly. Patients with these massive tears often 00:05:36.300 --> 00:05:39.860 have poor quality degenerative tendons with an 00:05:39.860 --> 00:05:43.000 inadequate blood supply. Like trying to sew old 00:05:43.000 --> 00:05:45.319 frayed fabric that doesn't get enough blood flow 00:05:45.319 --> 00:05:47.959 to mend? That's a very good analogy. The basic 00:05:47.959 --> 00:05:49.980 building blocks for healing just aren't optimal. 00:05:50.319 --> 00:05:52.759 These tendons can be thin, fragile, they have 00:05:52.759 --> 00:05:55.379 lost their elasticity. It makes getting a secure 00:05:55.379 --> 00:05:58.060 repair that actually holds and heals incredibly 00:05:58.060 --> 00:06:00.180 difficult. That makes sense. The material itself 00:06:00.180 --> 00:06:02.480 is compromised from the start. Precisely. And 00:06:02.480 --> 00:06:04.160 then you have patient demographics playing a 00:06:04.160 --> 00:06:06.870 role too. Like age. Yes, the review notes that 00:06:06.870 --> 00:06:10.050 healing outcomes are even worse in elderly patients, 00:06:10.449 --> 00:06:12.889 with inferior rates of both healing and recurrence. 00:06:13.110 --> 00:06:15.110 Which is entirely surprising, I guess. Healing 00:06:15.110 --> 00:06:17.829 generally slows down as we age. Right. You have 00:06:17.829 --> 00:06:20.790 general tissue degeneration, slower cell turnover, 00:06:21.149 --> 00:06:23.129 maybe reduced blood flow, other health conditions 00:06:23.129 --> 00:06:26.410 sometimes. It all stacks up against robust healing 00:06:26.410 --> 00:06:29.410 in older individuals compared to, say, a young 00:06:29.410 --> 00:06:31.920 healthy athlete with a traumatic tear. Okay, 00:06:31.959 --> 00:06:34.199 so we have poor tissue quality, high re -tier 00:06:34.199 --> 00:06:37.259 rates, factors like age. It sounds like a perfect 00:06:37.259 --> 00:06:40.120 storm of challenges. What does this mean for 00:06:40.120 --> 00:06:42.660 surgeons trying to get better results? It means 00:06:42.660 --> 00:06:45.139 there's a relentless drive for something better. 00:06:45.720 --> 00:06:48.959 The review emphasizes a really strong link. Those 00:06:48.959 --> 00:06:51.879 with healed rotator cuff repair have better clinical 00:06:51.879 --> 00:06:55.800 outcomes. So true healing equals better long 00:06:55.800 --> 00:06:58.819 -term results. Generally, yes. When the tendon 00:06:58.819 --> 00:07:01.600 genuinely heals and integrates properly, patients 00:07:01.600 --> 00:07:04.300 tend to report less pain, they regain more strength, 00:07:04.480 --> 00:07:06.240 and they're less likely to have the problem come 00:07:06.240 --> 00:07:08.339 back years later. And that's the motivation behind 00:07:08.339 --> 00:07:10.839 looking for new techniques and materials. Exactly. 00:07:11.040 --> 00:07:13.240 The goal isn't just symptom management. It's 00:07:13.240 --> 00:07:16.319 about promoting true biological structural healing 00:07:16.319 --> 00:07:18.579 that lasts. Which leads us directly to patch 00:07:18.579 --> 00:07:21.540 augmentation. Precisely. The whole idea behind 00:07:21.540 --> 00:07:24.319 using a patch is that it can potentially do two 00:07:24.319 --> 00:07:27.860 crucial things. First, It can mechanically reinforce 00:07:27.860 --> 00:07:30.560 the repair, make it stronger right away, like 00:07:30.560 --> 00:07:33.019 adding scaffolding. Taking the stress off the 00:07:33.019 --> 00:07:35.660 initial repair. Exactly. And second, ideally, 00:07:35.839 --> 00:07:38.420 it encourages biological healing. It might provide 00:07:38.420 --> 00:07:41.000 a scaffold for new tissue to grow into, maybe 00:07:41.000 --> 00:07:44.180 even deliver substances that stimulate the body's 00:07:44.180 --> 00:07:46.639 own repair processes. It's trying to give the 00:07:46.639 --> 00:07:49.259 body a helping hand, both physically and biologically. 00:07:49.439 --> 00:07:51.860 Okay, so a helping hand with a patch. It sounds 00:07:51.860 --> 00:07:53.939 simple, maybe like sticking a piece of tape over 00:07:53.939 --> 00:07:56.319 the tear, but I'm guessing it's much more complex 00:07:56.319 --> 00:07:58.160 than that. Oh, much more sophisticated, yes. 00:07:58.720 --> 00:08:01.560 At its core, patch augmentation means using an 00:08:01.560 --> 00:08:03.720 extra piece of material, the patch or graft, 00:08:04.259 --> 00:08:06.139 to strengthen the rotator cuff repair. But it's 00:08:06.139 --> 00:08:08.339 not just about strength, you said. No, the goal 00:08:08.339 --> 00:08:11.120 is really twofold. It needs to provide that immediate 00:08:11.120 --> 00:08:13.480 biomechanical support, protecting the fragile 00:08:13.480 --> 00:08:16.360 repair while it starts to heal. But it also aims 00:08:16.360 --> 00:08:19.860 to ideally induce native tissue growth. So it 00:08:19.860 --> 00:08:22.139 encourages the body's own tissue to grow into 00:08:22.139 --> 00:08:25.120 it. That's the hope. The ideal patch isn't just 00:08:25.120 --> 00:08:27.899 a passive support. It's meant to be a biologically 00:08:27.899 --> 00:08:30.800 active participant, a scaffold that encourages 00:08:30.800 --> 00:08:34.039 regeneration and eventually integrates, becoming 00:08:34.039 --> 00:08:37.080 part of the healed tendon. And this idea, using 00:08:37.080 --> 00:08:40.019 patches, it's not brand new, is it? The review 00:08:40.019 --> 00:08:42.639 mentions it has a history. That's a really important 00:08:42.639 --> 00:08:45.909 point. While it feels very modern, surgeons were 00:08:45.909 --> 00:08:48.350 experimenting with augmenting rotator cuff repairs 00:08:48.350 --> 00:08:50.950 decades ago, even back in the 80s. What kinds 00:08:50.950 --> 00:08:53.190 of materials were they using back then? Various 00:08:53.190 --> 00:08:55.429 things. Some early animal -derived tissues, some 00:08:55.429 --> 00:08:58.669 early synthetic materials. But those first attempts 00:08:58.669 --> 00:09:01.549 often ran into major problems. Like what? The 00:09:01.549 --> 00:09:04.240 big one was inflammation. The review describes 00:09:04.240 --> 00:09:07.360 a profound inflammatory reaction in many cases. 00:09:07.580 --> 00:09:09.940 Meaning the body saw the patch as foreign and 00:09:09.940 --> 00:09:11.779 attacked it. Essentially, yes. The immune system 00:09:11.779 --> 00:09:14.500 would mount a strong response trying to reject 00:09:14.500 --> 00:09:17.000 or wall off this foreign material. And as you 00:09:17.000 --> 00:09:20.559 can imagine, that led to poor outcomes, pain, 00:09:21.039 --> 00:09:23.519 stiffness, and ultimately... the failure of the 00:09:23.519 --> 00:09:26.240 augmentation. So a good idea in principle, but 00:09:26.240 --> 00:09:28.600 the materials weren't quite right biologically. 00:09:29.139 --> 00:09:31.580 Exactly. It was a really crucial lesson in biocompatibility. 00:09:32.000 --> 00:09:34.360 The material has to work with the body, not against 00:09:34.360 --> 00:09:36.940 it. So what changed? What allowed this concept 00:09:36.940 --> 00:09:39.399 to make such a comeback? The real game changer 00:09:39.399 --> 00:09:42.639 was technology, specifically breakthroughs in 00:09:42.639 --> 00:09:44.720 how these materials, especially animal -derived 00:09:44.720 --> 00:09:48.340 ones, are processed and purified. You mean cleaning 00:09:48.340 --> 00:09:51.620 them up better? In essence, yes. Take animal 00:09:51.620 --> 00:09:54.840 extracellular matrix, or ECM patches, that's 00:09:54.840 --> 00:09:57.639 the natural scaffold around cells. Modern versions 00:09:57.639 --> 00:10:00.399 go through much more modern and complete DNA 00:10:00.399 --> 00:10:03.080 extracting procedures. Removing the animal DNA? 00:10:03.500 --> 00:10:05.899 Primarily, yes. And other cellular components, 00:10:06.100 --> 00:10:09.440 debris. Basically anything that the human immune 00:10:09.440 --> 00:10:12.279 system is likely to react strongly against. Ah, 00:10:12.360 --> 00:10:15.120 so less foreign stuff means less inflammation. 00:10:15.500 --> 00:10:17.940 Precisely. This better processing leads to a 00:10:17.940 --> 00:10:20.159 significantly reduced inflammatory response. 00:10:20.740 --> 00:10:23.139 Often it's subclinical, meaning it's so mild 00:10:23.139 --> 00:10:25.299 the patient doesn't even notice it, and it doesn't 00:10:25.299 --> 00:10:27.220 interfere with healing. And that's why there's 00:10:27.220 --> 00:10:28.779 this renewed interest, because the patches are 00:10:28.779 --> 00:10:31.139 better tolerated now. That's a huge part of it. 00:10:31.620 --> 00:10:34.379 It resulted in a renewed interest in rotator 00:10:34.379 --> 00:10:37.509 cuff repair with patch augmentation. because 00:10:37.509 --> 00:10:39.730 it made successful integration much more likely, 00:10:39.970 --> 00:10:42.529 turning it from a risky experiment into a genuinely 00:10:42.529 --> 00:10:45.750 viable option. Okay, so with these better materials, 00:10:46.350 --> 00:10:48.149 what kinds of patches are actually being used 00:10:48.149 --> 00:10:50.190 now? The review breaks them down into categories, 00:10:50.350 --> 00:10:51.990 right? Yes, three main categories. First, you 00:10:51.990 --> 00:10:55.549 have xenographs. Xeno meaning foreign or other, 00:10:55.649 --> 00:10:58.220 so animal derived? Exactly. These come from animal 00:10:58.220 --> 00:11:01.120 tissues. Common ones are porcine dermal grafts 00:11:01.120 --> 00:11:04.460 from pigskin, or porcine small intestine submucosa, 00:11:04.600 --> 00:11:07.980 known as SAS. There's also bovine pericardium 00:11:07.980 --> 00:11:11.000 from cows, or even ovine foregut matrix from 00:11:11.000 --> 00:11:12.980 sheep. And these are heavily processed to remove 00:11:12.980 --> 00:11:15.960 the animal cells. Very heavily processed, decellularized, 00:11:16.100 --> 00:11:19.039 sterilized. The goal is to leave just the structural 00:11:19.039 --> 00:11:21.889 collagen framework. to act as a scaffold for 00:11:21.889 --> 00:11:24.370 human cells to grow into. Okay, so that's xenografts. 00:11:24.370 --> 00:11:26.610 What's the second category? That would be autografts 00:11:26.610 --> 00:11:29.190 and allografts. These are human -derived. Auto 00:11:29.190 --> 00:11:32.250 meaning self, allo meaning other, human. Correct. 00:11:33.149 --> 00:11:35.690 Autografts use the patient's own tissue. Maybe 00:11:35.690 --> 00:11:38.389 fascia lata from the thigh, part of the quadriceps 00:11:38.389 --> 00:11:41.690 tendon, or even a flap of preosteum, the membrane 00:11:41.690 --> 00:11:43.850 covering bone. The advantage there must be no 00:11:43.850 --> 00:11:46.610 rejection, right? Virtually zero risk of rejection, 00:11:46.909 --> 00:11:49.440 which is great. But the downside is you need 00:11:49.440 --> 00:11:51.399 a second surgery site to harvest that tissue, 00:11:51.820 --> 00:11:54.899 which brings its own potential problems. Pain, 00:11:55.259 --> 00:11:57.759 weakness, longer surgery time. OK, so that's 00:11:57.759 --> 00:11:59.980 autographs. What about allografts? Allografts 00:11:59.980 --> 00:12:02.620 use tissue from a human donor, usually deceased. 00:12:02.889 --> 00:12:05.730 A common one is a cellular human dermal graft 00:12:05.730 --> 00:12:08.090 skin that's been processed to remove all the 00:12:08.090 --> 00:12:10.669 donor cells, leaving just the collagen matrix. 00:12:10.990 --> 00:12:13.629 So similar processing to the xenografts, but 00:12:13.629 --> 00:12:16.129 starting with human tissue. Exactly. It avoids 00:12:16.129 --> 00:12:17.929 the second surgery site for the patient, but 00:12:17.929 --> 00:12:20.090 you still need rigorous screening and processing 00:12:20.090 --> 00:12:23.009 to ensure safety and minimize any potential immune 00:12:23.009 --> 00:12:24.909 response, though it's generally less vigorous 00:12:24.909 --> 00:12:27.090 than when xenografts. Got it. And the third category, 00:12:27.330 --> 00:12:29.529 the engineered ones. Synthetic grafts. These 00:12:29.529 --> 00:12:32.389 are man -made materials, polymers like polyester. 00:12:32.269 --> 00:12:35.269 polypropylene, polycarbonate polyurethane. Were 00:12:35.269 --> 00:12:38.070 the early ones just like inert meshes? Pretty 00:12:38.070 --> 00:12:40.490 much. Designed mostly for mechanical reinforcement. 00:12:41.389 --> 00:12:43.269 But the really exciting developments now are 00:12:43.269 --> 00:12:47.250 in things like nanoscaffolds. Nanoscaffolds? 00:12:47.250 --> 00:12:50.210 That sounds high tech. It is. Using techniques 00:12:50.210 --> 00:12:53.450 like 3D printing or electrospinning, researchers 00:12:53.450 --> 00:12:56.129 can create scaffolds at the nanoscale that are 00:12:56.129 --> 00:12:59.049 designed to very closely mimic the body's own 00:12:59.049 --> 00:13:02.120 natural tissue structure, the ECM. The idea being 00:13:02.120 --> 00:13:05.139 not just support, but actually guiding cell growth. 00:13:05.360 --> 00:13:07.779 Precisely. To create an environment that encourages 00:13:07.779 --> 00:13:10.419 cells to behave naturally, differentiate correctly, 00:13:10.600 --> 00:13:13.120 and regenerate healthy tissue, it's moving towards 00:13:13.120 --> 00:13:16.120 regenerative engineering. So xenograft, autograft, 00:13:16.259 --> 00:13:19.139 allograft, synthetic, each with its own history, 00:13:19.419 --> 00:13:22.399 pros, cons, and place in this search for the 00:13:22.399 --> 00:13:25.059 perfect patch, I guess. That's a great way to 00:13:25.059 --> 00:13:27.690 put it. And the review really digs into the scientific 00:13:27.690 --> 00:13:29.490 and clinical evidence for each of these, trying 00:13:29.490 --> 00:13:31.250 to see which ones are closest to achieving that 00:13:31.250 --> 00:13:33.429 ideal. Okay, let's get into that science then. 00:13:33.549 --> 00:13:35.549 We know the types, but how are they supposed 00:13:35.549 --> 00:13:37.970 to work? Let's start with biomechanics. From 00:13:37.970 --> 00:13:39.850 an engineering standpoint, what's the main goal? 00:13:40.110 --> 00:13:42.350 The primary biomechanical aim is straightforward. 00:13:43.190 --> 00:13:45.970 Make the repair stronger. You want to construct 00:13:45.970 --> 00:13:49.450 the tendon, plus the patch, that can handle significantly 00:13:49.450 --> 00:13:51.610 more load than the pendant repaired on its own. 00:13:52.009 --> 00:13:54.700 Why is that initial strength so critical? because 00:13:54.700 --> 00:13:57.919 the native tendon right after being sutured is 00:13:57.919 --> 00:14:00.759 incredibly weak and vulnerable. normal shoulder 00:14:00.759 --> 00:14:03.399 movements could potentially re -tear it. The 00:14:03.399 --> 00:14:06.379 patch acts like an internal brace, shielding 00:14:06.379 --> 00:14:08.779 the repair site from excessive stress during 00:14:08.779 --> 00:14:11.759 that crucial early healing phase. Like a protective 00:14:11.759 --> 00:14:14.240 shield while the real healing happens underneath. 00:14:14.519 --> 00:14:16.899 Exactly. It provides a window for the biological 00:14:16.899 --> 00:14:19.639 processes to kick in without the repair being 00:14:19.639 --> 00:14:21.740 immediately compromised by mechanical forces. 00:14:21.899 --> 00:14:24.039 And does the lab evidence back this up? Do these 00:14:24.039 --> 00:14:26.759 patches actually make the repair stronger? Yes. 00:14:27.240 --> 00:14:30.529 Generally they do. Lab studies, often using cadaver 00:14:30.529 --> 00:14:33.169 shoulders, which allow for control testing, have 00:14:33.169 --> 00:14:36.049 shown that synthetic patches, allografts, and 00:14:36.049 --> 00:14:38.090 the dermal xenografts, like the porcine ones, 00:14:38.809 --> 00:14:40.789 have all been shown to significantly increase 00:14:40.789 --> 00:14:42.889 construct strength and load to failure rates. 00:14:43.210 --> 00:14:45.029 Meaning they can take more force before breaking. 00:14:45.389 --> 00:14:47.669 Correct. Which is very encouraging for protecting 00:14:47.669 --> 00:14:50.490 the repair early on. However, it's not universal. 00:14:51.269 --> 00:14:54.250 Some materials, like that porcine SIS we mentioned, 00:14:54.750 --> 00:14:59.049 have shown less favorable outcomes biomechanically. 00:14:59.149 --> 00:15:01.370 These weren't as strong. Okay, so strength is 00:15:01.370 --> 00:15:04.169 good, but the review mentions this fascinating 00:15:04.169 --> 00:15:07.289 concept, the Goldilocks problem almost. You don't 00:15:07.289 --> 00:15:10.549 want it too strong. That sounds weird. It does 00:15:10.549 --> 00:15:12.769 sound counterintuitive, but it's a really critical 00:15:12.769 --> 00:15:15.590 point called stress shielding. Stress shielding. 00:15:15.610 --> 00:15:18.409 Explain that. Okay, imagine you put a ridiculously 00:15:18.409 --> 00:15:21.919 strong, rigid metal plate on a broken bone. That 00:15:21.919 --> 00:15:24.639 plate might take all the load, shielding the 00:15:24.639 --> 00:15:26.659 bone itself from the normal stresses it needs 00:15:26.659 --> 00:15:29.360 to stimulate healing and remodeling. The bone 00:15:29.360 --> 00:15:31.720 might not heal properly or could even weaken 00:15:31.720 --> 00:15:34.120 over time because this is not being worked. Ah, 00:15:34.120 --> 00:15:36.840 I see. The tissue needs some stress to heal correctly. 00:15:37.220 --> 00:15:39.820 Exactly. If the patch is too stiff and strong 00:15:39.820 --> 00:15:41.940 relative to the healing tendon, it can carry 00:15:41.940 --> 00:15:44.159 too much of the load. This prevents the tendon 00:15:44.159 --> 00:15:46.080 from getting the mechanical signals it needs 00:15:46.080 --> 00:15:48.659 to heal robustly and integrate with the patch. 00:15:48.860 --> 00:15:51.460 New tissue might not grow into the patch properly. 00:15:51.860 --> 00:15:54.659 So too strong is bad, but obviously too weak 00:15:54.659 --> 00:15:56.779 is also bad because it just fails. Precisely. 00:15:57.059 --> 00:15:59.440 If it's too weak, it doesn't provide enough protection 00:15:59.440 --> 00:16:02.519 and fails prematurely. So the ideal patch has 00:16:02.519 --> 00:16:04.919 to hit that sweet spot. Strong enough initially, 00:16:04.960 --> 00:16:07.259 but then what? What's the long -term goal for 00:16:07.259 --> 00:16:09.679 how it behaves? The real challenge. The ultimate 00:16:09.679 --> 00:16:12.970 goal. is to create a graft that provides that 00:16:12.970 --> 00:16:16.429 initial support but also actively encourages 00:16:16.429 --> 00:16:20.210 tissue infiltration and subsequent incorporation. 00:16:20.429 --> 00:16:23.470 Becoming part of the body. Ideally, yes, with 00:16:23.470 --> 00:16:25.809 desirable properties more similar to the native 00:16:25.809 --> 00:16:28.789 rotator cuff. The Dream is a patch that remodels 00:16:28.789 --> 00:16:31.549 over time, integrates fully, and eventually becomes 00:16:31.549 --> 00:16:34.450 biologically and functionally indistinguishable 00:16:34.450 --> 00:16:37.740 from a native tendon. True regeneration. not 00:16:37.740 --> 00:16:39.460 just a permanent reinforcement. Okay, that covers 00:16:39.460 --> 00:16:42.100 the mechanics. What about the histology? What's 00:16:42.100 --> 00:16:44.019 happening at the microscopic tissue level? Are 00:16:44.019 --> 00:16:46.120 we seeing this integration happen in human studies? 00:16:46.559 --> 00:16:48.139 Well, that's where the data gets a bit thinner. 00:16:48.600 --> 00:16:50.980 The review notes there are limited histological 00:16:50.980 --> 00:16:53.399 studies investigating patch use for rotator cuff 00:16:53.399 --> 00:16:56.039 repair in humans. Why so few? Is it hard to get 00:16:56.039 --> 00:16:59.139 tissue samples? Very hard, ethically and practically. 00:16:59.480 --> 00:17:01.659 You generally wouldn't do a biopsy on a healing 00:17:01.659 --> 00:17:04.019 tendon unless there was a clinical reason for 00:17:04.019 --> 00:17:07.660 re -operation. So much of our detailed histological 00:17:07.660 --> 00:17:10.319 understanding still comes from animal studies. 00:17:10.740 --> 00:17:13.619 Which are useful, but not always a perfect match 00:17:13.619 --> 00:17:16.220 for humans. Correct. They give us important clues, 00:17:16.680 --> 00:17:19.099 but we have to be cautious extrapolating directly. 00:17:19.539 --> 00:17:22.380 So based on the available studies, human and 00:17:22.380 --> 00:17:24.460 animal, what's the verdict at the tissue level? 00:17:24.839 --> 00:17:27.670 Do patches promote good healing? It's quite mixed, 00:17:27.769 --> 00:17:30.789 honestly. The review states there are variable 00:17:30.789 --> 00:17:33.410 healing outcomes with patch augmentation depending 00:17:33.410 --> 00:17:35.410 on the type of graft used. So it really depends 00:17:35.410 --> 00:17:38.170 on the specific material. Yes, and frustratingly, 00:17:38.430 --> 00:17:40.789 there's even disagreement among studies using 00:17:40.789 --> 00:17:43.289 the same material, which highlights how many 00:17:43.289 --> 00:17:45.849 factors are at play. Surgical technique, patient 00:17:45.849 --> 00:17:49.150 biology, how the histology was assessed. It's 00:17:49.150 --> 00:17:51.549 complex. But surely there must be some positive 00:17:51.549 --> 00:17:54.569 signs. Any materials that consistently show good 00:17:54.569 --> 00:17:57.460 tissue integration. Oh yes, definitely some promising 00:17:57.460 --> 00:17:59.920 findings. Human dermal allograft, for example, 00:18:00.059 --> 00:18:02.160 has generally performed well in histological 00:18:02.160 --> 00:18:05.539 studies. They see good signs like cellular infiltration, 00:18:05.880 --> 00:18:07.619 meaning the patient's own cells are moving into 00:18:07.619 --> 00:18:10.900 the graft, revascularization, new blood vessels 00:18:10.900 --> 00:18:13.619 forming, and evidence of new tendon formation. 00:18:13.769 --> 00:18:16.029 That sounds like exactly what you'd want to see. 00:18:16.430 --> 00:18:19.130 It is. Porcine dermal grafts have also yielded 00:18:19.130 --> 00:18:21.410 encouraging outcomes in animal studies, showing 00:18:21.410 --> 00:18:24.509 similar positive signs of integration. And autografts, 00:18:24.509 --> 00:18:27.609 being the patient's own tissue, also show encouraging 00:18:27.609 --> 00:18:30.730 histological outcomes in animal models with improved 00:18:30.730 --> 00:18:33.869 tendon healing. These are all good indicators 00:18:33.869 --> 00:18:36.309 that biological incorporation can happen. OK, 00:18:36.309 --> 00:18:37.869 but what about the other side of the coin? Any 00:18:37.869 --> 00:18:39.990 materials that looked less impressive under the 00:18:39.990 --> 00:18:44.420 microscope? Yes. That porcine SIS Again, despite 00:18:44.420 --> 00:18:47.519 some early animal optimism, human studies reported 00:18:47.519 --> 00:18:50.559 unsatisfactory outcomes, histologically, often 00:18:50.559 --> 00:18:53.180 showing inflammation, poor celling growth, not 00:18:53.180 --> 00:18:55.420 much new tissue. So the poor clinical results 00:18:55.420 --> 00:18:58.420 matched the poor tissue integration. Seems so. 00:18:58.759 --> 00:19:01.240 And some of the older synthetic grafts, like 00:19:01.240 --> 00:19:04.240 polyester, were often seen histologically as 00:19:04.240 --> 00:19:07.400 just remaining inert foreign bodies. They reinforced 00:19:07.400 --> 00:19:09.960 mechanically for a while, but didn't really integrate 00:19:09.960 --> 00:19:12.440 or promote new tissue growth within their structure. 00:19:12.640 --> 00:19:15.160 What about adverse reactions? You mentioned the 00:19:15.160 --> 00:19:17.559 inflammation issues with early patches. Is that 00:19:17.559 --> 00:19:19.980 still a major concern with the modern ones? It's 00:19:19.980 --> 00:19:22.339 always a consideration, but the situation has 00:19:22.339 --> 00:19:25.140 improved dramatically. While adverse reactions 00:19:25.140 --> 00:19:27.960 are now considered generally rare, they have 00:19:27.960 --> 00:19:30.839 been reported even with newer materials. Like 00:19:30.839 --> 00:19:33.640 what? Well, we already discussed the severe inflammatory 00:19:33.640 --> 00:19:36.500 reactions to porcine SIS. But interestingly, 00:19:36.859 --> 00:19:39.920 one study by Rashid et al. found that even some 00:19:39.920 --> 00:19:42.319 otherwise promising human allografts and porcine 00:19:42.319 --> 00:19:45.140 dermal grafts could occasionally cause significant 00:19:45.140 --> 00:19:47.519 disruption of the ECM of the underlying native 00:19:47.519 --> 00:19:49.880 tendon. Meaning they could actually damage the 00:19:49.880 --> 00:19:51.759 tendon they were supposed to help. In some cases, 00:19:51.980 --> 00:19:54.099 yes, leading to more fragile disorganized tissue 00:19:54.099 --> 00:19:56.960 underneath. It highlights how complex the host 00:19:56.960 --> 00:19:59.319 -graphed interaction is, and that even generally 00:19:59.319 --> 00:20:01.960 well -polarated materials aren't perfect in every 00:20:01.960 --> 00:20:04.559 single instance. But the review stresses that 00:20:04.559 --> 00:20:06.980 most of the severe reactions were seen with the 00:20:06.980 --> 00:20:09.599 older, less -purified models, right? Correct. 00:20:09.700 --> 00:20:12.240 And that's a crucial takeaway. The paper explicitly 00:20:12.240 --> 00:20:15.700 says most of these adverse reactions have investigated 00:20:15.700 --> 00:20:18.750 the earlier models. Thanks to the improved processing, 00:20:19.250 --> 00:20:21.569 especially the better DNA extraction for animal 00:20:21.569 --> 00:20:24.650 ECM patches, the inflammatory responses now are 00:20:24.650 --> 00:20:27.769 usually much milder, often subclinical. And these 00:20:27.769 --> 00:20:30.009 milder responses don't seem to hurt the clinical 00:20:30.009 --> 00:20:33.890 outcome. Generally, they seem not to affect clinical 00:20:33.890 --> 00:20:36.269 outcomes in most patients. It really underscores 00:20:36.269 --> 00:20:38.589 how critical that manufacturing and purification 00:20:38.589 --> 00:20:41.069 process is, not just for integration, but for 00:20:41.069 --> 00:20:43.789 basic safety and tolerance. So the lab work, 00:20:43.930 --> 00:20:46.130 the biomechanics, the histology, they give us 00:20:46.130 --> 00:20:48.789 a foundation. But the ultimate test is how these 00:20:48.789 --> 00:20:51.269 patches perform in real patients, isn't it? How 00:20:51.269 --> 00:20:53.529 do they actually affect recovery and long -term 00:20:53.529 --> 00:20:55.890 results in the clinic? Exactly. That's the crucial 00:20:55.890 --> 00:20:57.809 next step. And interpreting that clinical data 00:20:57.809 --> 00:21:00.710 as the review makes very clear is very challenging. 00:21:01.049 --> 00:21:04.269 OK. So why is it so challenging to get clear 00:21:04.269 --> 00:21:07.410 answers from the clinical studies? If surgeons 00:21:07.410 --> 00:21:10.069 are using these patches, shouldn't we know by 00:21:10.069 --> 00:21:13.089 now what works best? You'd think so, but there 00:21:13.089 --> 00:21:15.490 are several complicating factors. Firstly, there's 00:21:15.490 --> 00:21:18.230 just immense variety of implantation approaches, 00:21:18.769 --> 00:21:21.190 surgical techniques, and patches used. So different 00:21:21.190 --> 00:21:23.710 surgeons doing things differently. Exactly. Different 00:21:23.710 --> 00:21:25.789 patch materials, different ways of fixing them, 00:21:26.269 --> 00:21:28.769 open versus arthroscopic surgery, even different 00:21:28.769 --> 00:21:31.990 rehab protocols afterwards. All this variation 00:21:31.990 --> 00:21:35.799 leads to Highly variable outcomes that are really 00:21:35.799 --> 00:21:38.299 difficult to compare meaningfully across studies 00:21:38.299 --> 00:21:41.720 like comparing apples oranges and maybe pears 00:21:41.720 --> 00:21:45.240 pretty much Secondly many of the existing studies 00:21:45.240 --> 00:21:47.759 are relatively small or they're not direct comparisons 00:21:47.759 --> 00:21:50.619 between different patch types Often they have 00:21:50.619 --> 00:21:52.799 only a small number of comparative studies or 00:21:52.799 --> 00:21:55.160 research investigating each patch type often 00:21:55.160 --> 00:21:57.359 with a short follow -up period So we don't have 00:21:57.359 --> 00:22:00.420 enough big long -term head -to -head trials yet. 00:22:00.420 --> 00:22:02.819 Not nearly enough You need those kinds of studies 00:22:02.819 --> 00:22:05.960 to draw really definitive conclusions. So, given 00:22:05.960 --> 00:22:08.380 all that variability, what do we know? What's 00:22:08.380 --> 00:22:10.359 the range of results people are seeing? It's 00:22:10.359 --> 00:22:12.599 incredibly wide. A meta -analysis mentioned in 00:22:12.599 --> 00:22:15.980 the review by Uni et al. looked at retier rates 00:22:15.980 --> 00:22:18.799 after patch augmentation. They found the rates 00:22:18.799 --> 00:22:22.359 ranged anywhere from a really good 8 .3 % all 00:22:22.359 --> 00:22:25.569 the way up to a very disappointing 73 .4%. Wow, 00:22:25.809 --> 00:22:28.950 8 % to 73%, that's a massive difference. What 00:22:28.950 --> 00:22:30.990 determines where a study falls in that range? 00:22:31.109 --> 00:22:33.829 It depends heavily on the graft type indication 00:22:33.829 --> 00:22:36.210 and technique. Which patch was used? Why was 00:22:36.210 --> 00:22:38.990 it used for a primary repair, a revision, an 00:22:38.990 --> 00:22:41.509 irreparable tear? How was it put in? All these 00:22:41.509 --> 00:22:43.569 factors influence the outcome dramatically. Okay, 00:22:43.670 --> 00:22:45.799 let's try to break it down by type then. Starting 00:22:45.799 --> 00:22:48.359 with xenografts, the animal ones. The review 00:22:48.359 --> 00:22:50.460 suggested pretty mixed results there, a real 00:22:50.460 --> 00:22:53.200 learning process. Very mixed, yes. A clear example 00:22:53.200 --> 00:22:56.259 is porcine small intestine subucosa, the SIS 00:22:56.259 --> 00:22:58.680 patch. It consistently showed poor results in 00:22:58.680 --> 00:23:00.579 clinical trials. Like that big randomized trial 00:23:00.579 --> 00:23:04.450 you mentioned? Exactly. Iannotti et al. did a 00:23:04.450 --> 00:23:07.069 randomized control trial, a strong study design, 00:23:07.430 --> 00:23:10.029 and found no significant improvement with SIS. 00:23:10.549 --> 00:23:12.950 In fact, healing rates were worse than the SIS 00:23:12.950 --> 00:23:16.250 group. Only 27 % healed compared to 60 % of the 00:23:16.250 --> 00:23:18.410 control group without a patch. Worst healing. 00:23:18.529 --> 00:23:20.150 That's the opposite of what you want from an 00:23:20.150 --> 00:23:23.150 augmentation. Absolutely. Other studies by Bryant 00:23:23.150 --> 00:23:25.569 et al. and Slamberg et al. found similar things. 00:23:25.869 --> 00:23:30.180 No benefit. poor radiological outcomes, and unsatisfactory 00:23:30.180 --> 00:23:32.960 clinical outcomes, with Glambrook reporting a 00:23:32.960 --> 00:23:36.299 91 percent retire rate. So SIS was pretty much 00:23:36.299 --> 00:23:38.680 a dead end for a rotator cuff repair. It seems 00:23:38.680 --> 00:23:41.079 that way based on the evidence. It really illustrates 00:23:41.079 --> 00:23:43.500 that early promise in animal models doesn't always 00:23:43.500 --> 00:23:45.700 translate to human success. But what about other 00:23:45.700 --> 00:23:48.119 zener grafts? Did the porcine dermal grafts fare 00:23:48.119 --> 00:23:51.019 better? Much better, yes. Porcine dermal grafts 00:23:51.019 --> 00:23:53.099 have shown considerably more promise clinically. 00:23:53.240 --> 00:23:54.980 What kind of results are we talking about? Some 00:23:54.980 --> 00:23:57.240 studies are quite impressive. Avanzi et al. reported 00:23:57.240 --> 00:24:00.099 a healing rate of 97 .6 % in the patch group, 00:24:00.420 --> 00:24:02.859 which is remarkably high compared to just under 00:24:02.859 --> 00:24:05.460 60 % in their control group. They also saw better 00:24:05.460 --> 00:24:07.660 tendon thickness and function. That's a huge 00:24:07.660 --> 00:24:10.799 difference. It is. Castagna et al. found significant 00:24:10.799 --> 00:24:13.559 functional improvements even when using these 00:24:13.559 --> 00:24:16.539 patches for recurrent tears as a salvage option. 00:24:17.259 --> 00:24:20.019 Latermin et al. also reported significantly better 00:24:20.019 --> 00:24:23.079 functional scores. So a much more positive picture 00:24:23.079 --> 00:24:25.759 for this type of xenograft. And this is where 00:24:25.759 --> 00:24:27.700 the review highlights work involving Professor 00:24:27.700 --> 00:24:30.299 Imam and his colleagues, right? Their research 00:24:30.299 --> 00:24:33.259 seems to back up the promise of these porcine 00:24:33.259 --> 00:24:36.200 ECM graphs. Yes, absolutely. The paper specifically 00:24:36.200 --> 00:24:39.220 cites studies by Consiglier et al., a research 00:24:39.220 --> 00:24:41.319 group where Professor Mohammed Imam is a co -author. 00:24:41.619 --> 00:24:45.200 Their work in 2017 and 2021 looked at a denatured 00:24:45.200 --> 00:24:48.000 porcine ECM patch. And what did they find? They 00:24:48.000 --> 00:24:50.359 found significantly improved functional outcomes 00:24:50.359 --> 00:24:53.099 and pain scores compared to baseline. And importantly, 00:24:53.400 --> 00:24:56.400 their 2021 study reported lower structural failure 00:24:56.400 --> 00:25:00.380 rates, only about 15 .9 % re -tiers, which compared 00:25:00.380 --> 00:25:02.539 favorably to historical controls for similar 00:25:02.539 --> 00:25:05.140 large tiers repaired without a patch. So their 00:25:05.140 --> 00:25:07.880 own research directly contributes to this positive 00:25:07.880 --> 00:25:10.299 evidence base for certain xenografts? Precisely. 00:25:10.559 --> 00:25:13.759 It's a clear example of how the author's expertise, 00:25:14.220 --> 00:25:17.000 including Professor Immam's, has directly shaped 00:25:17.000 --> 00:25:19.920 our understanding and provided key data supporting 00:25:19.920 --> 00:25:22.519 these techniques. That's great to see. But even 00:25:22.519 --> 00:25:25.240 with these promising results, is it perfect? 00:25:25.700 --> 00:25:28.200 Are there any caveats for the porcine dermal 00:25:28.200 --> 00:25:30.740 graphs? As always, in medicine there's nuance. 00:25:31.500 --> 00:25:34.039 One study by Floriat et al. looks specifically 00:25:34.039 --> 00:25:37.099 at patients over 60 years old. They found that 00:25:37.099 --> 00:25:39.660 in this older group, the porcine dermal graft 00:25:39.660 --> 00:25:42.160 didn't lead to significantly better functional 00:25:42.160 --> 00:25:45.119 scores or lower retier rates compared to standard 00:25:45.119 --> 00:25:47.700 repair. Suggesting that age might still be a 00:25:47.700 --> 00:25:50.119 limiting factor even with a good patch. It might 00:25:50.119 --> 00:25:52.680 be, yes. Or perhaps the specific way it was used 00:25:52.680 --> 00:25:54.460 in that study. It just shows that effectiveness 00:25:54.460 --> 00:25:57.019 can still vary and patient selection remains 00:25:57.019 --> 00:25:59.319 really important. Okay, let's move to the human 00:25:59.319 --> 00:26:02.950 -derived grafts. Autographs and allografts. The 00:26:02.950 --> 00:26:05.470 reviews seem particularly positive about a cellular 00:26:05.470 --> 00:26:07.970 human dermal allografts. Are they emerging as 00:26:07.970 --> 00:26:10.170 a leader? The evidence certainly points in that 00:26:10.170 --> 00:26:12.170 direction. They appear to be the most consistently 00:26:12.170 --> 00:26:14.690 promising type based on current data. What makes 00:26:14.690 --> 00:26:17.190 the evidence so strong? Several well -designed 00:26:17.190 --> 00:26:20.609 studies show good results. Barber et al. did 00:26:20.609 --> 00:26:23.769 a prospective randomized study again, high quality 00:26:23.769 --> 00:26:25.829 evidence comparing standard repair -to -repair 00:26:25.829 --> 00:26:28.930 augmented with a human dermal allograft. And 00:26:28.930 --> 00:26:33.089 the results? Strikingly different. 85 % of patients 00:26:33.089 --> 00:26:36.150 in the augmented group had an intact cuff on 00:26:36.150 --> 00:26:39.150 MRI compared to only 40 % in the control group. 00:26:39.769 --> 00:26:41.809 They also had better functional outcomes and, 00:26:41.809 --> 00:26:44.549 importantly, no complications related to the 00:26:44.549 --> 00:26:47.730 graft itself. 85 % versus 40 % healed is a big 00:26:47.730 --> 00:26:50.660 deal. It really is. And other studies by Jilal, 00:26:50.779 --> 00:26:53.319 Petrie, Hall, and others have reported similarly 00:26:53.319 --> 00:26:55.819 positive outcomes, creating a consistent pattern 00:26:55.819 --> 00:26:58.299 of success for this specific type of allograft. 00:26:58.380 --> 00:27:00.579 Was there one study that directly compared different 00:27:00.579 --> 00:27:02.779 patch types and singled out the human dermal 00:27:02.779 --> 00:27:05.380 allograft? Yes, a study by Lusinger et al. in 00:27:05.380 --> 00:27:08.500 2016 did just that. They compared a xenograft, 00:27:08.819 --> 00:27:11.640 an allograft, specifically graft jacket, a human 00:27:11.640 --> 00:27:13.799 dermal product, and a synthetic graft. Their 00:27:13.799 --> 00:27:16.359 conclusion, the human dermal allograft yielded 00:27:16.359 --> 00:27:18.420 the best outcome scores. That's pretty compelling 00:27:18.420 --> 00:27:20.539 comparative evidence. It is. It really suggests 00:27:20.539 --> 00:27:22.599 that, based on what we know now, this material 00:27:22.599 --> 00:27:25.059 might be leading the pack. What about autographs 00:27:25.059 --> 00:27:27.140 using the patient's own tissue? Are they used 00:27:27.140 --> 00:27:29.519 often? Less often. Mainly because of that second 00:27:29.519 --> 00:27:31.940 surgical site needed for harvesting. That adds 00:27:31.940 --> 00:27:35.220 risk, pain, and recovery time. But they are still 00:27:35.220 --> 00:27:37.799 an option, maybe for specific situations? Yes. 00:27:38.079 --> 00:27:40.240 Crucial, perhaps, for patients who object to 00:27:40.240 --> 00:27:42.480 animal or donor tissue for personal or religious 00:27:42.480 --> 00:27:46.059 reasons. And they could work well. Mori, et al., 00:27:46.059 --> 00:27:49.299 showed significantly better outcomes, using fasciolata 00:27:49.299 --> 00:27:51.839 autographs for tears deemed irreparable otherwise. 00:27:52.339 --> 00:27:54.599 But the donor site is a real concern. It can 00:27:54.599 --> 00:27:57.160 be. Tempelair, et al., reported good shoulder 00:27:57.160 --> 00:28:00.400 outcomes, using quadriceps tendon autographs, 00:28:00.400 --> 00:28:02.640 but also noted high rates of complications at 00:28:02.640 --> 00:28:05.220 the donor site in the thigh. It's a trade -off. 00:28:05.380 --> 00:28:07.259 And there's a cautionary tale about autographs 00:28:07.259 --> 00:28:09.400 too, isn't there? Something about a periosteal 00:28:09.400 --> 00:28:13.039 flap. Ah, yes, the humoral periosteal flap. Initially, 00:28:13.119 --> 00:28:15.960 back in 2006, Scheibel et al. reported promising 00:28:15.960 --> 00:28:18.180 results using this flap of bone membrane from 00:28:18.180 --> 00:28:20.240 the upper arm bone. Looked good at first. Yes, 00:28:20.259 --> 00:28:23.339 but then a later study by Hollein et al. in 2019, 00:28:23.519 --> 00:28:25.519 with longer follow -up, found no improvement 00:28:25.519 --> 00:28:28.259 in healing response and actually unsatisfactory 00:28:28.259 --> 00:28:30.900 clinical outcomes. So the initial promise didn't 00:28:30.900 --> 00:28:33.660 hold up over time. Exactly. It led the researchers 00:28:33.660 --> 00:28:35.779 to conclude they could no longer recommend this 00:28:35.779 --> 00:28:38.599 approach. It's a vital lesson. Short -term results 00:28:38.599 --> 00:28:40.599 aren't always predictive, and medical evidence 00:28:40.599 --> 00:28:42.640 is constantly evolving based on longer -term 00:28:42.640 --> 00:28:45.980 data. A really important reminder. OK, last category. 00:28:46.640 --> 00:28:50.160 Synthetic and biologically enhanced graphs. What's 00:28:50.160 --> 00:28:53.160 their clinical story? The early synthetic graphs, 00:28:53.220 --> 00:28:56.160 like some polyesters, generally had poor long 00:28:56.160 --> 00:28:59.660 -term outcomes. That study by Renevo et al. with 00:28:59.660 --> 00:29:02.160 nearly 20 -year follow -up found poor results, 00:29:02.720 --> 00:29:05.359 and disturbingly, 75 % of patients developed 00:29:05.359 --> 00:29:08.480 cuff tear arthropathy. Severe arthritis caused 00:29:08.480 --> 00:29:11.200 by the failed repair. Yes, likely because the 00:29:11.200 --> 00:29:13.519 graft didn't integrate biologically, failed mechanically 00:29:13.519 --> 00:29:16.140 over time, and led to abnormal joint mechanics 00:29:16.140 --> 00:29:19.160 and degeneration. But newer synthetics are showing 00:29:19.160 --> 00:29:21.559 more potential. They are. Material science has 00:29:21.559 --> 00:29:24.220 advanced. Chionpi et al. found significantly 00:29:24.220 --> 00:29:26.680 improved function and retire rates using a newer 00:29:26.680 --> 00:29:30.299 polypropylene patch. And Kai et al. explored 00:29:30.299 --> 00:29:32.880 3D collagen scaffolds, finding better retire 00:29:32.880 --> 00:29:34.799 rates and tendon -bone integration in the short 00:29:34.799 --> 00:29:38.980 term. Do these newer synthetics still face that 00:29:38.980 --> 00:29:41.579 stress shielding problem? It remains a critical 00:29:41.579 --> 00:29:44.519 challenge, yes. Synthetics often have very different 00:29:44.519 --> 00:29:47.259 mechanical properties than native tendon, usually 00:29:47.259 --> 00:29:50.039 much stiffer. This mismatch can lead to that 00:29:50.039 --> 00:29:52.079 stress shielding effect, where the patch carries 00:29:52.079 --> 00:29:54.640 too much load, potentially hindering the natural 00:29:54.640 --> 00:29:56.859 healing and remodeling of the tendon itself. 00:29:57.480 --> 00:29:59.619 Finding that perfect balance of initial support 00:29:59.619 --> 00:30:01.880 and eventual load sharing is key. What about 00:30:01.880 --> 00:30:04.799 the really futuristic sounding ones, the nanoscaffolds? 00:30:05.079 --> 00:30:06.859 They've recently garnered more interest because 00:30:06.859 --> 00:30:09.720 their design at the nanoscale aims to mimic the 00:30:09.720 --> 00:30:12.599 natural ECM much more closely. The theory is 00:30:12.599 --> 00:30:15.220 this promotes better cell behavior and tissue 00:30:15.220 --> 00:30:17.180 regeneration. And is it working in practice? 00:30:17.839 --> 00:30:21.019 One study by Kim et al found superior tendon 00:30:21.019 --> 00:30:23.680 healing in animals. But the exact reasons why 00:30:23.680 --> 00:30:26.119 are still poorly understood. The big caveat is 00:30:26.119 --> 00:30:28.119 that we're still waiting on significant clinical 00:30:28.119 --> 00:30:30.980 trials at humans for these cutting -edge materials. 00:30:31.440 --> 00:30:34.200 Huge promise, but early days clinically. And 00:30:34.200 --> 00:30:37.059 finally, what about combining graphs with biological 00:30:37.059 --> 00:30:40.160 boosters, stem cells, growth factors? That's 00:30:40.160 --> 00:30:42.119 a really exciting area, trying to get the best 00:30:42.119 --> 00:30:45.200 of both mechanical support and biological stimulation. 00:30:45.549 --> 00:30:48.269 But the clinical results so far are quite mixed. 00:30:48.490 --> 00:30:51.750 Some positive, some not. Exactly. Jang et al. 00:30:52.170 --> 00:30:55.029 had good results combining a scaffold with mesenchymal 00:30:55.029 --> 00:30:58.569 stem cells in preclinical models. But Mensch 00:30:58.569 --> 00:31:02.509 et al. reported poor functional results when 00:31:02.509 --> 00:31:05.430 they tried adding PRP and bone marrow aspirate 00:31:05.430 --> 00:31:08.230 sources of growth factors in stem cells to a 00:31:08.230 --> 00:31:10.970 human dermal allograft in patients. So just adding 00:31:10.970 --> 00:31:14.019 biology isn't a guaranteed fix. It's... more 00:31:14.019 --> 00:31:16.700 complicated. It seems so. The timing, the dose, 00:31:16.920 --> 00:31:18.900 the specific factors, how they interact with 00:31:18.900 --> 00:31:21.579 the graft material, it all likely matters. There's 00:31:21.579 --> 00:31:24.160 lots of encouraging preclinical research, but 00:31:24.160 --> 00:31:27.180 the review concludes we urgently need well -designed 00:31:27.180 --> 00:31:29.720 prospective clinical trials to figure out how 00:31:29.720 --> 00:31:31.900 to make biological enhancement work reliably 00:31:31.900 --> 00:31:34.380 in humans. So a lot learned, but still much to 00:31:34.380 --> 00:31:35.920 figure out about the materials themselves. And 00:31:35.920 --> 00:31:37.779 as you said, the material is only half the story. 00:31:38.160 --> 00:31:40.420 How it's put in surgically is just as crucial. 00:31:40.660 --> 00:31:42.740 Absolutely. A perfect patch of material is useless 00:31:42.740 --> 00:31:44.519 if you can't get it in the right place and secure 00:31:44.519 --> 00:31:47.160 it properly. How has the surgical approach changed 00:31:47.160 --> 00:31:49.460 over time? Were these always done arthroscopically? 00:31:49.839 --> 00:31:52.759 No. Initially, many surgeons used traditional 00:31:52.759 --> 00:31:55.819 open surgery for these complex repairs and augmentations. 00:31:56.240 --> 00:31:58.920 Bigger incision, more dissection. But now... 00:31:58.920 --> 00:32:02.279 Now, with huge advancements in arthroscopic technology 00:32:02.279 --> 00:32:05.200 and skills, minimally invasive techniques are 00:32:05.200 --> 00:32:09.039 much more common. Pash augmentation done arthroscopically 00:32:09.039 --> 00:32:11.400 have gained popularity in recent years. Through 00:32:11.400 --> 00:32:13.960 those small keyhole incisions with a camera. 00:32:14.339 --> 00:32:16.900 Exactly. Less tissue trauma, potentially less 00:32:16.900 --> 00:32:20.690 pain, faster recovery. The review kind of implicitly 00:32:20.690 --> 00:32:23.289 shows this evolution in its figures moving from 00:32:23.289 --> 00:32:26.130 simpler concepts to more refined arthrostopic 00:32:26.130 --> 00:32:28.490 steps for deploying and fixing the patch. What 00:32:28.490 --> 00:32:30.609 were some of the early arthroscopic techniques 00:32:30.609 --> 00:32:33.049 like? Often they involved just overlaying the 00:32:33.049 --> 00:32:35.670 patch on top of the repaired tendon. It was mainly 00:32:35.670 --> 00:32:37.970 secured laterally at the bone attachment site 00:32:37.970 --> 00:32:40.769 without strong fixation on the inner medial side 00:32:40.769 --> 00:32:43.089 closer to the muscle. And why was that medial 00:32:43.089 --> 00:32:45.529 fixation found to be so important? This seems 00:32:45.529 --> 00:32:47.589 like a key insight highlighted in the review, 00:32:47.950 --> 00:32:50.089 particularly involving Professor Imam's group. 00:33:04.289 --> 00:33:10.150 So it needs to be fixed to the healthy tendon. 00:33:10.400 --> 00:33:13.240 medially as well as the bone laterally. Precisely. 00:33:13.440 --> 00:33:16.099 If it's only six laterally, it can't effectively 00:33:16.099 --> 00:33:18.779 bridge the gap and distribute the forces. The 00:33:18.779 --> 00:33:20.900 repair underneath might still see too much stress. 00:33:21.400 --> 00:33:23.420 It needs that kenshin band effect across the 00:33:23.420 --> 00:33:25.980 whole repair. And this led Professor Imam and 00:33:25.980 --> 00:33:28.559 his colleagues to develop a specific technique. 00:33:28.750 --> 00:33:31.250 the pullover technique. Yes, that's a fantastic 00:33:31.250 --> 00:33:33.369 example of their direct contribution to surgical 00:33:33.369 --> 00:33:36.049 innovation. The review explicitly mentions the 00:33:36.049 --> 00:33:38.910 pullover technique, described in a 2017 paper 00:33:38.910 --> 00:33:42.049 by Narvani, Imam, Polyzoius, and others. How 00:33:42.049 --> 00:33:44.109 does that work differently? Instead of just laying 00:33:44.109 --> 00:33:46.930 the patch flat on top, this technique involves 00:33:46.930 --> 00:33:49.890 strategically passing sutures to pull over or 00:33:49.890 --> 00:33:52.589 wrap the patch around the medial edge of the 00:33:52.589 --> 00:33:54.970 remaining healthy tendon cuff and securing it 00:33:54.970 --> 00:33:57.730 there, as well as laterally. It creates a more 00:33:57.730 --> 00:34:00.359 compressed encompassing, and biomechanically 00:34:00.359 --> 00:34:03.819 sound augmentation. So a more sophisticated way 00:34:03.819 --> 00:34:06.640 to achieve that crucial load sharing. Exactly. 00:34:07.099 --> 00:34:09.559 It represents a significant step forward from 00:34:09.559 --> 00:34:12.199 simple overlay techniques directly addressing 00:34:12.199 --> 00:34:14.699 that biomechanical need for medial stability. 00:34:14.960 --> 00:34:16.719 Are there other modern techniques being used 00:34:16.719 --> 00:34:19.099 now as well? Yes, the field keeps innovating. 00:34:19.750 --> 00:34:22.309 Surges now use special deployment devices. Think 00:34:22.309 --> 00:34:24.690 of them like sophisticated inserters to help 00:34:24.690 --> 00:34:27.389 position the patch accurately in the tight joint 00:34:27.389 --> 00:34:29.829 space arthroscopically. Making it easier and 00:34:29.829 --> 00:34:32.510 more reliable. That's the goal. And fixation 00:34:32.510 --> 00:34:34.510 methods have evolved, too. They might use special 00:34:34.510 --> 00:34:36.809 staples made of materials like polylactic acid 00:34:36.809 --> 00:34:40.469 or peak to secure the patch medially, anteriorly, 00:34:40.610 --> 00:34:43.269 and posteriorly, getting multiple points of fixation. 00:34:43.429 --> 00:34:46.030 But is there one single best way to do it now? 00:34:46.269 --> 00:34:49.409 Not yet. The review notes there's currently no 00:34:49.409 --> 00:34:51.769 consensus on any single method that should be 00:34:51.769 --> 00:34:54.190 used. It's still an area of active research, 00:34:54.369 --> 00:34:57.070 debate, and refinement. Different surgeons might 00:34:57.070 --> 00:34:58.969 prefer different techniques depending on the 00:34:58.969 --> 00:35:01.869 tear, the patch, and their own experience. The 00:35:01.869 --> 00:35:04.150 review also mentions that advancements in other 00:35:04.150 --> 00:35:06.389 complex shoulder surgeries might be helping push 00:35:06.389 --> 00:35:09.389 patch augmentation forward. Yes, there's definitely 00:35:09.389 --> 00:35:12.250 a crossover effect. Procedures like superior 00:35:12.250 --> 00:35:15.170 capsular reconstruction, or SCR, have become 00:35:15.170 --> 00:35:18.269 more popular for irreparable tears. And SCR also 00:35:18.269 --> 00:35:21.530 uses patches. Often, yes. A patch is used to 00:35:21.530 --> 00:35:23.349 reconstruct the top part of the joint capsule 00:35:23.349 --> 00:35:25.929 to restore stability. The development of better 00:35:25.929 --> 00:35:28.630 instruments, anchors, and techniques specifically 00:35:28.630 --> 00:35:31.650 for SCR has been a contributing factor to improving 00:35:31.650 --> 00:35:33.829 the tools available for patch augmentation of 00:35:33.829 --> 00:35:36.449 the rotator cuff too. They learn from each other. 00:35:36.769 --> 00:35:39.170 And Professor Imam has been involved in SCR research 00:35:39.170 --> 00:35:41.550 as well. Yes, the review mentions he co -authored 00:35:41.550 --> 00:35:44.849 a systematic review on SCR back in 2019, showing 00:35:44.849 --> 00:35:48.329 his broad expertise across complex shoulder reconstruction. 00:35:48.590 --> 00:35:51.070 There's also this intriguing belt and braces 00:35:51.070 --> 00:35:53.789 or hamburger technique mentioned, also linked 00:35:53.789 --> 00:35:56.250 to Professor Imam's group. What's that about? 00:35:56.730 --> 00:35:58.829 That's a really cutting edge concept described 00:35:58.829 --> 00:36:01.949 in a paper by Memmon, Imam, and colleagues in 00:36:01.949 --> 00:36:06.349 2020. The idea is to combine both patch augmentation 00:36:06.349 --> 00:36:09.389 of the rotator cuff and an SCR procedure. Two 00:36:09.389 --> 00:36:12.289 patches essentially, one on top, one maybe underneath 00:36:12.289 --> 00:36:14.610 or acting as the capsule. Kind of like that, 00:36:14.630 --> 00:36:17.250 hence the hamburger analogy. You have the repaired 00:36:17.250 --> 00:36:20.440 cuff. augmented with a patch, the belt, and then 00:36:20.440 --> 00:36:23.179 an SCR construct as well, the braces. The goal 00:36:23.179 --> 00:36:26.139 is maximum stability and healing potential for 00:36:26.139 --> 00:36:28.639 the most severely damaged shoulders. Has that 00:36:28.639 --> 00:36:30.840 been proven in clinical trials yet? Not yet. 00:36:31.039 --> 00:36:33.579 The review states that clinical trials are yet 00:36:33.579 --> 00:36:36.179 to be completed. But it represents the kind of 00:36:36.179 --> 00:36:37.940 innovative thinking happening at the forefront, 00:36:38.679 --> 00:36:40.940 combining techniques to tackle the toughest problems 00:36:40.940 --> 00:36:43.460 driven by experts like Professor Imam and his 00:36:43.460 --> 00:36:46.159 collaborators. So materials are improving, techniques 00:36:46.159 --> 00:36:48.420 are getting more sophisticated. It feels like 00:36:48.420 --> 00:36:50.059 we're definitely heading in the right direction. 00:36:50.400 --> 00:36:52.239 But what are the big remaining questions? What 00:36:52.239 --> 00:36:54.369 does the road ahead look like? Well, one of the 00:36:54.369 --> 00:36:56.530 really fascinating points the review brings up 00:36:56.530 --> 00:36:59.250 is this persistent disconnect we sometimes see. 00:36:59.650 --> 00:37:03.170 The radiological outcomes, what an MRI or ultrasound 00:37:03.170 --> 00:37:05.630 shows about the tendon healing, do not always 00:37:05.630 --> 00:37:08.670 match the clinical outcomes the patient experiences. 00:37:09.409 --> 00:37:11.530 You mentioned this earlier, patients feeling 00:37:11.530 --> 00:37:14.630 better even if the scan shows a retier. Exactly. 00:37:15.050 --> 00:37:17.449 Especially with larger tears or in older patients, 00:37:17.610 --> 00:37:21.039 many still do well clinically. Their pain is 00:37:21.039 --> 00:37:23.820 better, function is improved, even if the structural 00:37:23.820 --> 00:37:26.659 repair isn't perfect on imaging. So does that 00:37:26.659 --> 00:37:28.480 mean the structural healing doesn't matter as 00:37:28.480 --> 00:37:32.380 much as we thought? Not necessarily. While symptom 00:37:32.380 --> 00:37:35.119 relief is paramount, the authors, including Professor 00:37:35.119 --> 00:37:37.719 Imam, strongly argue that the evidence still 00:37:37.719 --> 00:37:40.860 shows those with well -healed tendons do have 00:37:40.860 --> 00:37:43.840 superior clinical outcomes in the long run. better 00:37:43.840 --> 00:37:46.539 durability, maybe less chance of problems later. 00:37:46.699 --> 00:37:49.480 That's the idea. A truly healed tendon is likely 00:37:49.480 --> 00:37:51.780 to provide more sustained pain relief, better 00:37:51.780 --> 00:37:54.460 strength, and be less prone to later degeneration 00:37:54.460 --> 00:37:56.840 or retearing compared to one that hasn't healed 00:37:56.840 --> 00:37:58.920 structurally, even if the patient feels okay 00:37:58.920 --> 00:38:01.420 initially. So the ultimate goal isn't just good 00:38:01.420 --> 00:38:04.099 clinical outcomes anymore. The ambition for the 00:38:04.099 --> 00:38:06.980 next decade, as the paper puts it, should be 00:38:06.980 --> 00:38:10.079 to not only have good clinical outcomes but also 00:38:10.079 --> 00:38:13.010 improve the tendon healing rate. It's about achieving 00:38:13.010 --> 00:38:15.610 both making patients feel better and ensuring 00:38:15.610 --> 00:38:18.329 the underlying biology is truly restored for 00:38:18.329 --> 00:38:21.150 long -term success. How do the experts, like 00:38:21.150 --> 00:38:23.449 Professor Imam and his co -authors, propose we 00:38:23.449 --> 00:38:26.349 get there? The review outlines some key strategies, 00:38:26.710 --> 00:38:29.309 right? Three pillars for future progress. Yes, 00:38:29.429 --> 00:38:31.769 they lay out a clear roadmap. Pillar number one 00:38:31.769 --> 00:38:34.110 is the continued development of patches resembling 00:38:34.110 --> 00:38:37.280 native tissue. Creating graphs that mimic natural 00:38:37.280 --> 00:38:39.840 tendon as closely as possible in all aspects, 00:38:40.320 --> 00:38:42.380 mechanically, structurally, biologically. To 00:38:42.380 --> 00:38:45.059 overcome stress shielding and encourage seamless 00:38:45.059 --> 00:38:47.619 integration. Exactly. If the patch behaves almost 00:38:47.619 --> 00:38:49.840 identically to the native tissue, the body is 00:38:49.840 --> 00:38:52.280 more likely to accept it, remodel it, and integrate 00:38:52.280 --> 00:38:54.860 it fully. Okay, pillar one. Better mimicking. 00:38:54.980 --> 00:38:57.199 What's biller two? Biological enhancement of 00:38:57.199 --> 00:38:59.639 patches. This is about actively stimulating healing, 00:39:00.139 --> 00:39:02.039 using things like stem cells, growth factors, 00:39:02.219 --> 00:39:04.460 or other bioactive molecules incorporated into 00:39:04.460 --> 00:39:07.380 the patch itself. Moving beyond a passive scaffold 00:39:07.380 --> 00:39:10.239 to an active delivery system for healing signals. 00:39:10.579 --> 00:39:12.780 Precisely. Giving the body's repair processes 00:39:12.780 --> 00:39:15.719 a direct boost right at the site of injury. It's 00:39:15.719 --> 00:39:18.239 about actively promoting regeneration at the 00:39:18.239 --> 00:39:20.699 cellular level. And the third pillar. This sounds 00:39:20.699 --> 00:39:24.860 more practical. Surgical. It is. Improved instrumentation. 00:39:25.059 --> 00:39:27.699 Developing better, more intuitive tools for surgeons 00:39:27.699 --> 00:39:30.480 to arthroscopically delivering and stabilizing 00:39:30.480 --> 00:39:33.500 the patches consistently and reliably without 00:39:33.500 --> 00:39:35.780 adding significantly to surgical time. Because 00:39:35.780 --> 00:39:37.880 even the best patch is useless if it's too hard 00:39:37.880 --> 00:39:40.500 to put in correctly. Absolutely. Surgical efficiency, 00:39:41.019 --> 00:39:43.460 reproducibility, and minimizing operative time 00:39:43.460 --> 00:39:46.099 are critical for any technique to be widely adopted 00:39:46.099 --> 00:39:48.920 and successful in the real world. Ease of use 00:39:48.920 --> 00:39:51.480 matters. Right. So combining those three pillars, 00:39:51.579 --> 00:39:54.059 mimicking native tissue, biologically enhancing 00:39:54.059 --> 00:39:56.280 it, and making it easy to implant that leads 00:39:56.280 --> 00:39:58.619 to the vision of the perfect patch. That's the 00:39:58.619 --> 00:40:00.719 ultimate goal described in the paper, a patch 00:40:00.719 --> 00:40:03.500 that provides the right initial biomechanical 00:40:03.500 --> 00:40:07.260 reinforcement actively, biologically promotes 00:40:07.260 --> 00:40:10.079 healing and cellular infiltration without an 00:40:10.079 --> 00:40:13.320 adverse tissue reaction, and is also easy to 00:40:13.320 --> 00:40:15.739 deliver surgically and stabilize it arthroscopically. 00:40:15.900 --> 00:40:18.579 It's a tall order, but it sounds like the direction 00:40:18.579 --> 00:40:20.940 the field is heading. It is. It's about creating 00:40:20.940 --> 00:40:23.539 a solution that works on all levels, mechanically, 00:40:23.760 --> 00:40:26.280 biologically, and practically. But despite all 00:40:26.280 --> 00:40:28.940 this progress and exciting potential, are there 00:40:28.940 --> 00:40:32.659 still big unanswered questions, ongoing debates? 00:40:32.940 --> 00:40:35.440 Oh, definitely. The review acknowledges there's 00:40:35.440 --> 00:40:38.320 still debate over the superiority of patch augmentation 00:40:38.320 --> 00:40:40.980 over standard repairs in terms of healing improvement, 00:40:41.400 --> 00:40:43.559 especially when you consider all types of tiers 00:40:43.559 --> 00:40:46.400 and patients. It's not yet definitively proven 00:40:46.400 --> 00:40:48.530 better for everyone. which means we need more 00:40:48.530 --> 00:40:51.630 research. Urgently. The paper concludes with 00:40:51.630 --> 00:40:54.070 a very strong call for high -quality prospective 00:40:54.070 --> 00:40:57.329 clinical trials. We need large, well -designed 00:40:57.329 --> 00:40:59.570 studies that directly compare different graft 00:40:59.570 --> 00:41:01.969 types against each other and against standard 00:41:01.969 --> 00:41:04.510 repair, looking carefully at both clinical and 00:41:04.510 --> 00:41:06.989 radiological outcomes. Randomized controlled 00:41:06.989 --> 00:41:09.090 trials, the gold standard. Exactly. They need 00:41:09.090 --> 00:41:11.570 to be sufficiently powered to give clear answers 00:41:11.570 --> 00:41:15.000 and randomized to avoid bias. That's how we'll 00:41:15.000 --> 00:41:17.159 really know which patches work best, for which 00:41:17.159 --> 00:41:19.340 patients, and using which techniques. So the 00:41:19.340 --> 00:41:21.920 journey is far from over, even with these incredible 00:41:21.920 --> 00:41:24.659 advancements. Far from over, but incredibly promising. 00:41:25.320 --> 00:41:27.679 Patch augmentation is, without doubt, an exciting 00:41:27.679 --> 00:41:30.679 topic. It represents a major step forward, and 00:41:30.679 --> 00:41:33.000 as the review predicts, it will surely be the 00:41:33.000 --> 00:41:35.679 subject of many scientific discussions in the 00:41:35.679 --> 00:41:38.440 next decade. The potential for truly improving 00:41:38.440 --> 00:41:40.800 how we treat these debilitating injuries is immense. 00:41:42.579 --> 00:41:45.400 Wow, what a fascinating deep dive. We've really 00:41:45.400 --> 00:41:46.980 covered a lot of ground today. We started with 00:41:46.980 --> 00:41:49.039 the significant challenge of massive rotator 00:41:49.039 --> 00:41:51.900 cuff tears, those high re -tier rates, the difficulties 00:41:51.900 --> 00:41:54.400 in healing. Then we traced the evolution of patch 00:41:54.400 --> 00:41:56.920 augmentation from early problematic attempts 00:41:56.920 --> 00:42:00.300 to the modern, better tolerated xenografts, allografts, 00:42:00.320 --> 00:42:02.559 and a potential of synthetics. We explored the 00:42:02.559 --> 00:42:04.900 intricate science, the biomechanics of load sharing 00:42:04.900 --> 00:42:07.340 and stress shielding, the histological evidence 00:42:07.340 --> 00:42:10.099 of tissue integration, both good and bad. And 00:42:10.099 --> 00:42:13.000 we looked at the real world clinical data. which 00:42:13.000 --> 00:42:15.500 is complex but shows real promise for certain 00:42:15.500 --> 00:42:18.780 materials like human dermal allografts and modern 00:42:18.780 --> 00:42:21.440 porcine dermal grafts, including the important 00:42:21.440 --> 00:42:23.579 contributions from research involving Professor 00:42:23.579 --> 00:42:26.460 Mohammed Imam and his team. We also touched on 00:42:26.460 --> 00:42:28.480 how surgical techniques have evolved, becoming 00:42:28.480 --> 00:42:31.320 less invasive and more sophisticated, with innovations 00:42:31.320 --> 00:42:34.539 like medial stabilization and the pullover technique, 00:42:34.920 --> 00:42:37.159 again highlighting Professor Imam's contributions 00:42:37.159 --> 00:42:39.500 to the field. And finally, we looked ahead at 00:42:39.500 --> 00:42:42.239 the ongoing quest for the perfect patch. one 00:42:42.239 --> 00:42:45.300 that mimics native tissue, boosts biology, and 00:42:45.300 --> 00:42:47.760 is easy for surgeons to use while acknowledging 00:42:47.760 --> 00:42:50.199 the crucial need for more high -quality trials. 00:42:50.460 --> 00:42:53.019 The key takeaway seems to be that patch augmentation, 00:42:53.500 --> 00:42:55.400 used selectively and with the right materials 00:42:55.400 --> 00:42:57.760 and techniques, holds real potential to improve 00:42:57.760 --> 00:43:00.199 outcomes for patients struggling with these difficult 00:43:00.199 --> 00:43:03.179 tiers. But it's a field that's definitely still 00:43:03.179 --> 00:43:06.440 evolving. Maturing, yes, with lots more to learn. 00:43:06.800 --> 00:43:10.500 So... As you, our listener, consider the incredible 00:43:10.500 --> 00:43:13.119 complexity of the human shoulder and the sheer 00:43:13.119 --> 00:43:15.360 ingenuity of the medical science trying to repair 00:43:15.360 --> 00:43:18.000 it, maybe you're left wondering something similar 00:43:18.000 --> 00:43:21.920 to what I am. How close are we, really, to creating 00:43:21.920 --> 00:43:25.199 truly regenerative solutions, like living biological 00:43:25.199 --> 00:43:27.820 spare parts that fully integrate? And what other 00:43:27.820 --> 00:43:29.739 parts of the body might benefit from this kind 00:43:29.739 --> 00:43:32.179 of approach, pushing the boundaries of healing 00:43:32.179 --> 00:43:34.699 and regeneration? Fascinating thought. Thank 00:43:34.699 --> 00:43:36.590 you for joining us on the Deep Dive. We hope 00:43:36.590 --> 00:43:38.670 this exploration has sparked your curiosity. 00:43:39.250 --> 00:43:39.690 Until next time.